These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 20657163

  • 1. Role of IgE in eosinophilic otitis media.
    Iino Y.
    Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
    [Abstract] [Full Text] [Related]

  • 2. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y, Usubuchi H, Kodama K, Kanazawa H, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [Abstract] [Full Text] [Related]

  • 3. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
    Kanazawa H, Yoshida N, Shinnabe A, Iino Y.
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
    [Abstract] [Full Text] [Related]

  • 4. New Insights into Eosinophilic Otitis Media.
    Kanazawa H, Yoshida N, Iino Y.
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [Abstract] [Full Text] [Related]

  • 5. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S.
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [Abstract] [Full Text] [Related]

  • 6. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y.
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [Abstract] [Full Text] [Related]

  • 7. Clinical characteristics of so called eosinophilic otitis media.
    Nagamine H, Iino Y, Kojima C, Miyazawa T, Iida T.
    Auris Nasus Larynx; 2002 Jan; 29(1):19-28. PubMed ID: 11772486
    [Abstract] [Full Text] [Related]

  • 8. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Usubuchi H, Kodama K, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media.
    Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.
    Otol Neurotol; 2012 Sep; 33(7):1218-24. PubMed ID: 22825324
    [Abstract] [Full Text] [Related]

  • 10. Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant.
    Han YE, Kang YS, Cho Y, Park MK.
    J Int Adv Otol; 2018 Apr; 14(1):144-147. PubMed ID: 29764789
    [Abstract] [Full Text] [Related]

  • 11. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma.
    Iino Y, Nagamine H, Yabe T, Matsutani S.
    Clin Exp Allergy; 2001 Jul; 31(7):1135-43. PubMed ID: 11468006
    [Abstract] [Full Text] [Related]

  • 12. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y, Takahashi E, Ida S, Kikuchi S.
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Nagamine H, Kakizaki K, Komiya T, Katano H, Saruya S, Kodera K.
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [Abstract] [Full Text] [Related]

  • 16. IgG4 Expression in Patients with Eosinophilic Otitis Media.
    Takahashi M, Oka A, Kariya S, Gion Y, Sato Y, Iwasaki S, Oyamada S, Matsubara A, Okano M.
    ORL J Otorhinolaryngol Relat Spec; 2021 Dec; 83(3):167-171. PubMed ID: 33691317
    [Abstract] [Full Text] [Related]

  • 17. Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatment.
    Esu Y, Masuda M, Yoshida N.
    Auris Nasus Larynx; 2020 Aug; 47(4):527-535. PubMed ID: 32586742
    [Abstract] [Full Text] [Related]

  • 18. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H, Yoshida N, Yamamoto H, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Iino Y.
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [Abstract] [Full Text] [Related]

  • 19. Atopic allergy and otitis media with effusion.
    Boedts D, De Groote G, Van Vuchelen J.
    Acta Otolaryngol Suppl; 1984 Dec; 414():108-14. PubMed ID: 6598258
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
    Iino Y, Tomioka-Matsutani S, Matsubara A, Nakagawa T, Nonaka M.
    Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.